China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.
SXTC stock price ended at $2.63 on 星期四, after rising 5.62%
On the latest trading day Feb 12, 2026, the stock price of SXTC rose by 5.62%, climbing from $2.54 to $2.63. During the session, the stock saw a volatility of 13.69%, with prices oscillating between a daily low of $2.41 and a high of $2.74. Notably, trading volume dropped by 32.7K shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 140.6K shares were traded, equating to a market value of approximately $305.1M.
